Cellbae’s TEP@RT Antigen Rapid Test has received authorisation by Health Sciences Authority - the 1st COVID-19 ART that is developed, manufactured in Singapore.
The Health Sciences Authority (HSA) has granted interim authorisation under the Pandemic Special Access Route (PSAR) for Spikevax Bivalent Original/Omicron COVID-19 vaccine by Moderna on 14 September 2022.
SINGAPORE, Sept 14 The Health Sciences Authority (HSA) today granted interim authorisation for Moderna's updated vaccine, which can target both the original Sars-CoV-2.
The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Moderna’s Spikevax COVID-19 vaccine via the Pandemic Special Access Route.